Biogen Reports Earnings Wednesday. Here's What to Expect.

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 38 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 97%

Nederland Nieuws Nieuws

Nederland Laatste Nieuws,Nederland Headlines

Wall Street will likely be more interested in updates on future developments, rather than the latest quarter's numbers.

Biogen , under new CEO Chris Viehbacher, is in a period of cost-cutting, and trying to build out a new Alzheimer’s disease franchise. There’s not much mystery around the trajectory of its older products, sales of which are flat or dropping.

That number was lower than some had anticipated, but analysts wrote that sales growth was expected to be slow for Leqembi. Eisai’s American depositary receipt dropped 4.8% on the results at midday Tuesday. Also on Tuesday, Biogen partner Sage Therapeutics said it will price the postpartum depression drug Zurzuvae—which the companies are commercializing together—at $15,900 for a two-week treatment course. Leerink Partners analyst Marc Goodman wrote that the price is lower than expected, and shares of Sage were down 4.9% at midday.

Analysts expect Biogen to report sales of $2.4 billion for the third quarter of its fiscal year, and earnings of $3.97 per share. In the same period last year, earnings were $4.77 per share.

Wij hebben dit nieuws samengevat zodat u het snel kunt lezen. Bent u geïnteresseerd in het nieuws, dan kunt u hier de volledige tekst lezen. Lees verder:

 /  🏆 3. in NL
 

Bedankt voor uw reactie. Uw reactie wordt na beoordeling gepubliceerd.

Nederland Laatste Nieuws, Nederland Headlines

Similar News:Je kunt ook nieuwsberichten lezen die vergelijkbaar zijn met deze die we uit andere nieuwsbronnen hebben verzameld.

Disney earnings: What to expect when the Magic Kingdom reportsJon Swartz is a senior reporter for MarketWatch in San Francisco, covering many of the biggest players in tech, including Netflix, Facebook and Google. Jon has covered technology for more than 20 years, and previously worked for Barron's and USA Today. Follow him on Twitter jswartz.
Bron: MarketWatch - 🏆 3. / 97 Lees verder »

Rivian Reports Earnings Today. What to Expect.Wall Street is looking for a per-share loss of $1.31 from sales of $1.3 billion, according to Bloomberg. Rivian reported a $1.08 loss from sales of $1.1...
Bron: MarketWatch - 🏆 3. / 97 Lees verder »

Lucid Reports Earnings Today. What to Expect.Wall Street projects a per share loss of 40 cents from sales of about $178 million, according to Bloomberg. Lucid reported a 40 cent loss from sales of $151...
Bron: MarketWatch - 🏆 3. / 97 Lees verder »

UFC and WWE Owner TKO Reports First Quarterly EarningsThe Endeavor-controlled company completed its merger of the WWE and UFC in September.
Bron: THR - 🏆 411. / 53 Lees verder »

GlobalFoundries rises after topping earnings expectationsGlobalFoundries rises after topping earnings expectations
Bron: Investingcom - 🏆 450. / 53 Lees verder »

Brink’s Q3 earnings top estimatesCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Bron: MarketWatch - 🏆 3. / 97 Lees verder »